Penelope M. Webb Australian epidemiologist
Webb, Penny, 1963-....
Webb, Penny
VIAF ID: 14169139 (Personal)
Permalink: http://viaf.org/viaf/14169139
Preferred Forms
- 100 0 _ ‡a Penelope M. Webb ‡c Australian epidemiologist
-
-
-
- 100 1 _ ‡a Webb, Penny ‡d 1963-
- 100 1 _ ‡a Webb, Penny ‡d 1963-
-
-
- 100 1 _ ‡a Webb, Penny, ‡d 1963-
-
-
-
- 100 1 _ ‡a Webb, Penny, ‡d 1963-....
4xx's: Alternate Name Forms (11)
Works
Title | Sources |
---|---|
Epidemiologia : podręcznik dla studentów i praktyków | |
Essential epidemiology : an introduction for students and health professionals | |
Patterns of, and barriers to supportive care needs assessment and provision for Australian women with gynecological cancer and their caregivers: a mixed-methods study of clinical practice | |
Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: a prospective population-based study over the last year of life | |
Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study. | |
Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma | |
Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer | |
Predicting vitamin D deficiency in older Australian adults | |
Predictors of sexual well-being after endometrial cancer: results of a national self-report survey. | |
Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor. | |
Prevalence, predictors, and correlates of supportive care needs among women 3-5 years after a diagnosis of endometrial cancer. | |
Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort | |
The proportion of cancers attributable to social deprivation: A population-based analysis of Australian health data | |
Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression: a prospective analysis. | |
Quality of life of women with lower limb swelling or lymphedema 3-5 years following endometrial cancer. | |
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. | |
Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients | |
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer | |
Re: Excess of early onset multiple myeloma in endometrial cancer probands and their relatives suggests common susceptibility. | |
Re: Predictive Value of Symptoms for Early Detection of Ovarian Cancer | |
Recreational and occupational field exposure to freshwater cyanobacteria--a review of anecdotal and case reports, epidemiological studies and the challenges for epidemiologic assessment | |
Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium | |
Recruitment and Results of a Pilot Trial of Vitamin D Supplementation in the General Population of Australia | |
Recurrence ofHelicobacter pyloriinfection in adults with intellectual disability | |
Reducing time to diagnosis does not improve outcomes for women with symptomatic ovarian cancer: a report from the Australian Ovarian Cancer Study Group. | |
Repeatability of self-reported information for population-based studies of cancer | |
Reply to J. Moline et al | |
Reproducibility of food and nutrient intake estimates using a semi-quantitative FFQ in Australian adults | |
Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis | |
Response to van Diest, Zweemer, and Piek | |
The return to work experiences of middle-aged Australian workers diagnosed with colorectal cancer: a matched cohort study | |
Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum? | |
Risk Stratification for Melanoma: Models Derived and Validated in a Purpose-Designed Prospective Cohort | |
Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence | |
The role of glutathione-S-transferase polymorphisms in ovarian cancer survival | |
S1169 KCNN4 Gene Variant Is Associated with Ileal Crohn's Disease | |
Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study | |
Searching for cancer deaths in Australia: National Death Index vs. cancer registries | |
Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis. | |
Serum HE4 as a prognostic marker in endometrial cancer--a population based study | |
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer | |
Shared heritability and functional enrichment across six solid cancers | |
Short-term cancer risks associated with oral contraceptives are balanced by longer term benefits | |
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer | |
Smoking and Cutaneous Melanoma: Findings from the QSkin Sun and Health Cohort Study | |
Statin use and survival following a diagnosis of ovarian cancer: A prospective observational study | |
Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer | |
A systematic literature review of trials of survivorship interventions for women with gynaecological cancer and their caregivers | |
Tea consumption and risk of ovarian cancer | |
The toxins of Lyngbya majuscula and their human and ecological health effects. | |
Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future | |
Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. | |
Type I and II endometrial cancers: have they different risk factors? | |
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium | |
The use of nonsteroidal anti-inflammatory drugs and the risk of Barrett's oesophagus. | |
Use of talcum powder and endometrial cancer risk. | |
Variation in bone morphogenetic protein 15 is not associated with spontaneous human dizygotic twinning | |
Variations in adjuvant chemotherapy and survival in women with epithelial ovarian cancer - a population-based study | |
Vitamin D for prevention of chronic disease: the need for continued research | |
When will I feel normal again? Trajectories and predictors of persistent symptoms and poor wellbeing after primary chemotherapy for ovarian cancer | |
Women's perceptions of their lifestyle and quality of life several years after a diagnosis of endometrial cancer. | |
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk |